Orforglipron: The First Oral GLP-1 Pill for Weight Loss and Diabetes

Weight Loss

Written By Sidhi Nathwani - updated 12/10/2026 08:00Reviewed By Aliysha Parveen - 02/10/2025 11:00
Share:

What is Orforglipron?

Orforglipron (Foundayo) is a once-daily GLP-1 weight loss pill developed by Eli Lilly. Unlike current GLP-1 medications that require weekly injections, Orforglipron is taken as a simple tablet making it one of the most anticipated new options for people looking for a needle-free approach to treatment.

Orforglipron has received MHRA approval and you can now place your order for Foundayo (orforglipron) pills today for delivery as soon as the next day.

How does it work?

Orforglipron is a GLP-1 receptor agonist. It works similarly to other GLP-1 medicines by mimicking glucagon-like peptide-1, a hormone which regulates appetite and food intake.

By activating GLP-1 receptors, Orforglipron helps to:

  • Slow down stomach emptying

  • Decrease hunger cues in the brain

  • Improve insulin sensitivity

  • Increase feelings of fullness

In doing so, it can help regulate blood sugar levels and reduce cravings and hunger. Collectively, this leads to a reduced calorie intake and thus, weight loss.

Additional Health Benefits

Like other GLP-1 agonists, studies suggest Orforglipron may help to reduce cardiovascular risk factors,supporting better heart health alongside weight reduction.

What are the Benefits of Orforglipron for Weight Loss?

The most significant benefit of Orforglipron is how it's taken. Currently licensed GLP-1 medications like Wegovy and Mounjaro are administered via once-weekly injection. Orforglipron is an exception as a daily oral pill. Choosing a tablet over an injection offers several advantages:

  • Painless - No needles or skin irritation.

  • Convenient - No need for refrigeration, fitting into busy lifestyles or travel schedules.

  • Less waste - No need for replacement needles or bulky sharps disposal bins.

Additionally, Orforglipron is the first small-molecule GLP-1 medication showing successful results in clinical trials. Its small-molecule structure makes it easier to be absorbed by the digestive tract, without strict fasting rules.

How Effective is Orforglipron? Clinical Trial Results

In a 36-week trial focused on weight loss, participants lost an average of 9.4% to 14.7% of their body weight taking Orforlipron, compared to just 2.3% in the placebo group. Additionally:

  • 10% weight loss - between 46% and 75% of participants lost 10% or more of their total body weight.

  • Waist circumference reduction - Participants saw a significant reduction in waist circumference, an average of 5.6cm to 9.6cm.

Orforglipron for Type 2 Diabetes

In trials involving participants with type 2 diabetes, Orforglipron consistently outperformed older diabetes medications like dulaglutide and placebo.

Over 40 weeks, data from over 500 participants shows an average blood sugar reduction of up to 1.6% - compared to 0.4% with placebo and 1.1% with dulaglutide.

Although this trial primarily measures blood sugar level changes, it also looks at body weight changes. An average 4.7-7.9% body weight reduction was found in the group taking Orforglipron compared to just 1.6% in the placebo group. It was also noted that the weight loss had not plateaued when the trial ended at 40 weeks, so participants could go on to lose more weight.

Orforglipron vs. Wegovy vs. Mounjaro

So how does the new tablet compare to existing licensed treatments Wegovy and Mounjaro? Whilst trial durations differ, early comparisons show Orforglipron is in the same league as the injectables:

Medication

How its taken

% Patients Achieving at least 10% Weight Loss

Orforglipron

Once-daily tablet

46% - 75% (at 36 weeks)

Wegovy

Once-weekly injection

45% - 75% (in longer studies)

Mounjaro

Once-weekly injection

63% - 94% (in longer studies)

When Will Orforglipron Be Available in the UK?

Orforglipron received MHRA approval on the 10th August 2026 which means you can obtain it through private clinics/pharmacies. You can now order Orforglipron from Quick Meds by clicking here and filling out a consultation form. Your form will then be reviewed by one of our clinicians who will assess if the medication is suitable for you. If suitable they will generate a prescription and you will have your medication delivered to you as soon as the next day.

Who is Orforglipron For?

Orforglipron will be suitable for adults who:

  • Have a BMI (body mass index) ≥30.

  • Have a BMI ≥27 with a weight-related health condition (such as high blood pressure, sleep apnoea.

  • Prefer a tablet over an injection.

  • Have struggled to lose weight through lifestyle changes alone.

Orforglipron is a prescription-only (POM) medicine, so a clinical check with a prescriber will be needed before taking the medication to check if it is safe for you.

Prescribing criteria will be different for people taking the medication for weight loss and for type 2 diabetes.

How is Orforglipron Taken?

Orforglipron is taken as a once-daily tablet. Doses range from 0.8mg to 17.2mg. When you start treatment, your prescriber will likely use a gradual titration schedule. This means starting at the lowest dose, which is then slowly increased every 30 days, allowing the body time to adapt to the medication, minimising side effects. This is the same way currently licensed GLP-1 medicines are prescribed.

Unlike other oral weight loss treatments, there are no specific fasting requirements or restrictions around when food and drink can be consumed. This will be appealing to those who are looking for an effective treatment without the complexity of injections or strict dosing routines.

What are Orforglipron side effects?

As with all medications, Orforglipron can cause side effects, though not everyone gets them. In line with other GLP-1 agonists, most side effects involve the digestive system, especially when starting treatment or increasing the dose.

Frequency

Side effects

Management

Very Common

- Nausea

- Mild diarrhoea

- Vomiting

- Eat smaller meals

- Avoid fatty/spicy foods

- Remain hydrated

Common

- Indigestion

- Abdominal pain

- Reflux

- Fatigue

- Usually settles within a few weeks whilst remaining on the same dose.

Rare/Serious

- Acute pancreatitis

- Gallbladder disorders

- Severe dehydration/kidney distress

- Seek immediate medical attention

Lifestyle Tips to Maximise Your Weight Loss

As with any weight loss medication, the treatments are only as good as the lifestyle changes made alongside them.

The key is sustainable choices - changes which are effective but not too drastic that they cannot be continued. To get the best results on your weight loss journey, consider the following:

  • Prioritise protein - to preserve lean muscle as you lose fat.

  • Stay active - incorporate regular exercise, a mixture of strength training with cardiovascular exercise.

  • Focus on fibre - vegetables, whole grains and legumes to support digestion.

  • Adequate hydration - drink plenty of water, to help minimise some side effects.

  • Eat mindfully - chew slowly and listen to your body’s early fullness cues. Avoid drinking excess alcohol or sugary drinks. .

  • Prioritise sleep.

Why Buy Orforglipron Online in the UK from Quick Meds?

Quick Meds is a fully registered UK online pharmacy regulated by the GPhC and MHRA. Our team of prescribing pharmacists is dedicated to helping you find the safest, most effective weight management solutions for your needs.

How Our Service Works

  1. Online consultation - complete an online consultation, which asks about your weight, medical history and if you take other medication.

  2. Clinical review - our prescribing pharmacists review your details, ensuring treatment will be safe and appropriate.

  3. Discreet delivery - Approved orders are dispensed and packed in plain packaging, and shipped directly to you, with fast, tracked delivery.

References:

https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists 

https://pmc.ncbi.nlm.nih.gov/articles/PMC12898445/ 

https://www.nejm.org/doi/full/10.1056/NEJMoa2302392 

https://pubmed.ncbi.nlm.nih.gov/37369232/

Frequently Asked Questions

Everything you need to know

Is Orforglipron a pill or an injection?
+−

Orforglipron is a once-daily oral tablet (pill). It is unique as it's the first GLP-1 medication not formulated as a weekly injection.

Is Orforglipron approved in the UK?
+−

Yes. Orforglipron received MHRA approval on 10th August

Do I need to fast before taking Orforglipron?
+−

No. unlike other oral GLP-1 medicines (like Rybelsus or Wegovy) which requires you to wait 30 minutes before eating or drinking, Orforglipron is a small-molecule drug that's easily absorbed. Clinical trial data shows there are no strict fasting requirements or food restrictions when taking it.

Do I need a prescription?
+−

Yes, Orforglipron is a prescription-only medication. Our team at Quick Meds will prescribe Orforglipron to all eligible patients.

Is it better than Wegovy or Mounjaro?
+−

Orforglipron promotes similar weight loss to other products, with the added advantage of being a pill. There's no need for injections or refrigeration.

What are the most common side effects?
+−

Common side effects of Orforglipron seem to affect the gastrointestinal system. This includes vomiting, nausea, diarrhoea, and constipation. Click here to see our full blog post on Orforglipron side effects